APOE stands for apolipoprotein E, a gene that helps the body move cholesterol and other fats. Different versions of this gene can affect a person's risk of developing Alzheimer's disease. One version, called APOE4, is linked to a higher risk, but having it does not mean someone will definitely get Alzheimer's.
What Does the APOE Gene Do?
The APOE gene gives the body instructions for making a protein called apolipoprotein E. This protein helps carry cholesterol and other fats through the bloodstream. These fats are important for normal cell function, including the function of cells in the brain.
Everyone has the APOE gene. What differs from person to person is which version of the gene they inherit. These versions can influence how likely someone is to develop certain health conditions, including Alzheimer's disease.
According to MedlinePlus Genetics, the APOE gene has three major forms: APOE2, APOE3, and APOE4. The APOE4 form is associated with a greater risk of late-onset Alzheimer's disease, which generally occurs after age 65.
What Are the Three Types of APOE?
The three common forms of APOE have different associations with Alzheimer's risk. Scientists call these forms alleles, meaning different versions of the same gene.
- APOE2 (ε2): This is the least common of the three major forms. It may offer some protection against Alzheimer's disease compared with other forms.
- APOE3 (ε3): This is the most common form. It is generally considered neutral because it does not appear to substantially increase or decrease Alzheimer's risk.
- APOE4 (ε4): This form is associated with a higher likelihood of developing Alzheimer's disease. Its effect on risk can differ between individuals and populations.
Each person inherits two copies of APOE, one from each biological parent. As a result, someone may have two copies of the same version or a combination of different versions.
The six possible combinations are APOE2/2, APOE2/3, APOE2/4, APOE3/3, APOE3/4, and APOE4/4. These combinations are sometimes called APOE genotypes.
How Does APOE4 Affect Alzheimer's Risk?
APOE4 is an important genetic risk factor for Alzheimer's disease, particularly the more common late-onset form. People who inherit one APOE4 copy have a higher risk than people without it. Those who inherit two copies generally have an even greater risk.
The Alzheimer's Association explains that APOE4 is one of the most influential known genetic risk factors for Alzheimer's in certain populations. However, the amount of risk associated with APOE4 can vary with genetic ancestry and other factors.
For example, a person with APOE3/4 has one copy of the higher-risk version, while someone with APOE4/4 has two. The second combination is generally linked to a greater likelihood of Alzheimer's, but neither result provides a certain prediction of what will happen.
Researchers have also observed that APOE4 may be associated with Alzheimer's symptoms appearing at a younger age in some populations.
Why Is APOE4 Linked to Alzheimer's Disease?
Scientists are still investigating exactly how APOE4 influences Alzheimer's development.
One important finding involves amyloid plaques. These are abnormal collections of a protein fragment called amyloid-beta that build up in the brains of people with Alzheimer's disease.
Research has linked APOE4 with greater amyloid plaque accumulation in affected brain tissue. Amyloid buildup is one of the biological changes associated with Alzheimer's disease and may contribute to nerve cell damage.
However, APOE4 does not act alone. Alzheimer's is a complex disease influenced by several genetic and non-genetic factors. Having a higher-risk gene version does not fully explain why one person develops the disease while another does not.
Is APOE the Same as an Alzheimer's Gene That Causes the Disease?
No. APOE is mainly considered a risk gene rather than a gene that directly determines whether someone will develop Alzheimer's.
A risk gene changes the probability of developing a disease. It does not guarantee the disease will occur.
In contrast, certain rare inherited changes in genes called APP, PSEN1, and PSEN2 can directly cause familial Alzheimer's disease, often with symptoms beginning before age 65.
Mayo Clinic distinguishes APOE4 from these rare disease-causing gene changes. It explains that APOE4 increases the likelihood of Alzheimer's without directly causing it, whereas certain inherited mutations in APP, PSEN1, and PSEN2 can cause young-onset Alzheimer's.
This distinction matters when families discuss genetic risk. A relative having Alzheimer's does not automatically mean other family members will develop it or that a rare disease-causing mutation is present.
Can an APOE Genetic Test Tell You if You Will Get Alzheimer's?
An APOE genetic test can identify which versions of the APOE gene a person carries. It cannot determine with certainty whether that person will develop Alzheimer's disease.
APOE testing may be performed using a blood sample or another suitable DNA sample. Results commonly identify combinations such as APOE3/3, APOE3/4, or APOE4/4.
According to the Alzheimer's Association's guidance on medical testing, routine APOE genetic testing is not recommended as a way to diagnose Alzheimer's disease or predict an individual's future with certainty. Genetic testing should be discussed with a physician or genetic counselor before proceeding.
When might APOE testing be useful?
Although APOE testing is not a routine screening test for healthy adults, it can be relevant in specific circumstances.
- Research participation: Researchers may use APOE results when studying Alzheimer's risk, disease progression, or treatment responses.
- Specialist treatment decisions: APOE status may help doctors assess certain treatment-related risks in people with diagnosed Alzheimer's disease.
- Genetic counseling: A specialist may help someone understand an existing APOE result, especially when there are concerns about family history.
Some direct-to-consumer genetic testing services also report APOE results. These results require careful interpretation because they do not provide a complete picture of a person's dementia risk.
Does APOE4 Matter When Choosing Alzheimer's Treatment?
APOE4 can be relevant when doctors consider certain treatments for early Alzheimer's disease.
For example, lecanemab is an anti-amyloid treatment used for eligible people with early Alzheimer's disease. One of its important potential side effects is amyloid-related imaging abnormalities, or ARIA, which can involve swelling or bleeding in the brain.
The Alzheimer's Association's information about lecanemab explains that people who carry APOE4 may have a higher risk of ARIA. Genetic testing before treatment can help inform discussions about that risk.
This is different from using APOE testing to predict whether a healthy person will develop Alzheimer's. In the treatment setting, genetic information may help a specialist weigh the benefits and risks of a particular medicine.
APOE status alone does not determine whether someone needs treatment or which treatment is suitable.
What Should You Do if You Have the APOE4 Gene?
Learning that you carry APOE4 can raise questions about your future health and your family's risk. The most useful next step is to understand the result in context rather than treating it as a diagnosis.
A doctor or genetic counselor can explain what your specific APOE combination means, how family history may affect its interpretation, and whether further assessment is appropriate.
If you or someone close to you is experiencing ongoing memory problems, increasing confusion, or changes in thinking that interfere with daily activities, arrange a medical evaluation. A healthcare professional may consider the symptoms, medical history, cognitive testing, and other investigations to understand the cause.
Age, overall health, family history, and other factors all contribute to Alzheimer's risk. APOE is one part of that larger picture.
The Bottom Line
APOE is a gene involved in the body's handling of cholesterol and other fats. Its three common versions—APOE2, APOE3, and APOE4—are associated with different levels of Alzheimer's disease risk.
APOE4 is linked to increased risk, especially when a person inherits two copies, but it is not a definite prediction of Alzheimer's disease. Genetic testing can identify APOE versions, while a healthcare professional can help explain their significance and whether testing has a useful role in an individual's care.